- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02141399
En langsigtet sikkerhedsundersøgelse af ALKS 5461
21. november 2018 opdateret af: Alkermes, Inc.
En fase 3 multicenterundersøgelse af den langsigtede sikkerhed og tolerabilitet af ALKS 5461 til supplerende behandling af svær depressiv lidelse hos voksne, der har en utilstrækkelig respons på antidepressiv terapi (FORWARD-2-undersøgelsen)
Dette er et 52-ugers åbent studie for at evaluere sikkerheden og tolerabiliteten af ALKS 5461.
Studieoversigt
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
1485
Fase
- Fase 3
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Queensland
-
Towong, Queensland, Australien, 4066
- Alkermes Investigational Site
-
-
Victoria
-
Frankston, Victoria, Australien, 3199
- Alkermes Investigational Site
-
Melbourne, Victoria, Australien, 3004
- Alkermes Investigational Site
-
-
-
-
-
Bourgas, Bulgarien, 8001
- Alkermes Investigational Site
-
Kazanlak, Bulgarien, 6100
- Alkermes Investigational Site
-
Sofia, Bulgarien, 1113
- Alkermes Investigational Site
-
Sofia, Bulgarien, 1431
- Alkermes Investigational Site
-
Sofia, Bulgarien, 1632
- Alkermes Investigational Site
-
Varna, Bulgarien, 9020
- Alkermes Investigational Site
-
Veliko Turnovo, Bulgarien, 5000
- Alkermes Investigational Site
-
Vratza, Bulgarien, 3000
- Alkermes Investigational Site
-
-
-
-
-
Quebec, Canada, G3K 2P8
- Alkermes Investigational Site
-
-
British Columbia
-
Penticton, British Columbia, Canada, V2A 4M4
- Alkermes Investigational Site
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3S 1L8
- Alkermes Investigational Site
-
-
Quebec
-
Gatineau, Quebec, Canada, J8T 8JL
- Alkermes Investigational Site
-
-
-
-
Alabama
-
Birmingham, Alabama, Forenede Stater, 35294
- Alkermes Investigational Site
-
Birmingham, Alabama, Forenede Stater, 35226
- Alkermes Investigational Site
-
-
Arizona
-
Tucson, Arizona, Forenede Stater, 85712
- Alkermes Investigational Site
-
-
Arkansas
-
Little Rock, Arkansas, Forenede Stater, 72211
- Alkermes Investigational Site
-
-
California
-
Bellflower, California, Forenede Stater, 90706
- Alkermes Investigational Site
-
Beverly Hills, California, Forenede Stater, 90210
- Alkermes Investigational Site
-
Carson, California, Forenede Stater, 90746
- Alkermes Investigational Site
-
Garden Grove, California, Forenede Stater, 92845
- Alkermes Investigational Site
-
Glendale, California, Forenede Stater, 91206
- Alkermes Investigational Site
-
Los Alamitos, California, Forenede Stater, 90720
- Alkermes Investigational Site
-
Los Angeles, California, Forenede Stater, 90024
- Alkermes Investigational Site
-
National City, California, Forenede Stater, 91950
- Alkermes Investigational Site
-
Oakland, California, Forenede Stater, 94612
- Alkermes Investigational Site
-
Oceanside, California, Forenede Stater, 92056
- Alkermes Investigational Site
-
Orange, California, Forenede Stater, 92868
- Alkermes Investigational Site
-
Pico Rivera, California, Forenede Stater, 90660
- Alkermes Investigational Site
-
Redlands, California, Forenede Stater, 92374
- Alkermes Investigational Site
-
San Gabriel, California, Forenede Stater, 91776
- Alkermes Investigational Site
-
Sherman Oaks, California, Forenede Stater, 91403
- Alkermes Investigational Site
-
Temecula, California, Forenede Stater, 92591
- Alkermes Investigational Site
-
Torrance, California, Forenede Stater, 90502
- Alkermes Investigational Site
-
Upland, California, Forenede Stater, 91786
- Alkermes Investigational Site
-
-
Colorado
-
Colorado Springs, Colorado, Forenede Stater, 80910
- Alkermes Investigational Site
-
Denver, Colorado, Forenede Stater, 80209
- Alkermes Investigational Site
-
-
Connecticut
-
Hartford, Connecticut, Forenede Stater, 06106
- Alkermes Investigational Site
-
Norwich, Connecticut, Forenede Stater, 06360
- Alkermes Investigational Site
-
-
Florida
-
Bradenton, Florida, Forenede Stater, 34201
- Alkermes Investigational Site
-
Coral Springs, Florida, Forenede Stater, 33067
- Alkermes Investigational Site
-
Fort Myers, Florida, Forenede Stater, 33912
- Alkermes Investigational Site
-
Gainesville, Florida, Forenede Stater, 32607
- Alkermes Investigational Site
-
Hallandale Beach, Florida, Forenede Stater, 33009
- Alkermes Investigational Site
-
Hialeah, Florida, Forenede Stater, 33016
- Alkermes Investigational Site
-
Jacksonville, Florida, Forenede Stater, 32256
- Alkermes Investigational Site
-
Lauderhill, Florida, Forenede Stater, 33319
- Alkermes Investigational Site
-
Maitland, Florida, Forenede Stater, 32751
- Alkermes Investigational Site
-
Melbourne, Florida, Forenede Stater, 32901
- Alkermes Investigational Site
-
North Miami, Florida, Forenede Stater, 33161
- Alkermes Investigational Site
-
Oakland Park, Florida, Forenede Stater, 33334
- Alkermes Investigational Site
-
Orlando, Florida, Forenede Stater, 32801
- Alkermes Investigational Site
-
Tampa, Florida, Forenede Stater, 33613
- Alkermes Investigational Site
-
The Villages, Florida, Forenede Stater, 32162
- Alkermes Investigational Site
-
West Palm Beach, Florida, Forenede Stater, 33407
- Alkermes Investigational Site
-
Winter Haven, Florida, Forenede Stater, 33880
- Alkermes Investigational Site
-
-
Georgia
-
Alpharetta, Georgia, Forenede Stater, 30005
- Alkermes Investigational Site
-
Atlanta, Georgia, Forenede Stater, 30308
- Alkermes Investigational Site
-
Decatur, Georgia, Forenede Stater, 30030
- Alkermes Investigational Site
-
Smyrna, Georgia, Forenede Stater, 30080
- Alkermes Investigational Site
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60640
- Alkermes Investigational Site
-
Chicago, Illinois, Forenede Stater, 60634
- Alkermes Investigational Site
-
Deerfield, Illinois, Forenede Stater, 60015
- Alkermes Investigational Site
-
Hoffman Estates, Illinois, Forenede Stater, 60169
- Alkermes Investigational Site
-
Joliet, Illinois, Forenede Stater, 60435
- Alkermes Investigational Site
-
Oak Brook, Illinois, Forenede Stater, 60523
- Alkermes Investigational Site
-
Skokie, Illinois, Forenede Stater, 60076
- Alkermes Investigational Site
-
-
Indiana
-
Indianapolis, Indiana, Forenede Stater, 46260
- Alkermes Investigational Site
-
Lafayette, Indiana, Forenede Stater, 47905
- Alkermes Investigational Site
-
Newburgh, Indiana, Forenede Stater, 47630
- Alkermes Investigational Site
-
Valparaiso, Indiana, Forenede Stater, 46383
- Alkermes Investigational Site
-
-
Kentucky
-
Edgewood, Kentucky, Forenede Stater, 41017
- Alkermes Investigational Site
-
Owensboro, Kentucky, Forenede Stater, 42301
- Alkermes Investigational Site
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21208
- Alkermes Investigational Site
-
Baltimore, Maryland, Forenede Stater, 21204
- Alkermes Investigational Site
-
Washington D.C., Maryland, Forenede Stater, 20016
- Alkermes Investigational Site
-
-
Massachusetts
-
Belmont, Massachusetts, Forenede Stater, 02478
- Alkermes Investigational Site
-
Brockton, Massachusetts, Forenede Stater, 02301
- Alkermes Investigational Site
-
Watertown, Massachusetts, Forenede Stater, 02472
- Alkermes Investigational Site
-
Worcester, Massachusetts, Forenede Stater, 01655
- Alkermes Investigational Site
-
-
Mississippi
-
Flowood, Mississippi, Forenede Stater, 39232
- Alkermes Investigational Site
-
-
Missouri
-
O'Fallon, Missouri, Forenede Stater, 63368
- Alkermes Investigational Site
-
Saint Charles, Missouri, Forenede Stater, 63304
- Alkermes Investigational Site
-
Saint Louis, Missouri, Forenede Stater, 63141
- Alkermes Investigational Site
-
Saint Louis, Missouri, Forenede Stater, 63109
- Alkermes Investigational Site
-
-
New Jersey
-
Berlin, New Jersey, Forenede Stater, 80091
- Alkermes Investigational Site
-
Cherry Hill, New Jersey, Forenede Stater, 08002
- Alkermes Investigational Site
-
Princeton, New Jersey, Forenede Stater, 08540
- Alkermes Investigational Site
-
-
New Mexico
-
Albuquerque, New Mexico, Forenede Stater, 87109
- Alkermes Investigational Site
-
-
New York
-
Brooklyn, New York, Forenede Stater, 11241
- Alkermes Investigational Site
-
Jamaica, New York, Forenede Stater, 11432
- Alkermes Investigational Site
-
Mount Kisco, New York, Forenede Stater, 10549
- Alkermes Investigational Site
-
New York, New York, Forenede Stater, 10168
- Alkermes Investigational Site
-
New York, New York, Forenede Stater, 10029
- Alkermes Investigational Site
-
New York, New York, Forenede Stater, 10128
- Alkermes Investigational Site
-
New York, New York, Forenede Stater, 10019
- Alkermes Investigational Site
-
New York, New York, Forenede Stater, 10023
- Alkermes Investigational Site
-
Staten Island, New York, Forenede Stater, 10312
- Alkermes Investigational Site
-
Staten Island, New York, Forenede Stater, 10305
- Alkermes Investigational Site
-
-
North Carolina
-
Charlotte, North Carolina, Forenede Stater, 28204
- Alkermes Investigational Site
-
High Point, North Carolina, Forenede Stater, 27265
- Alkermes Investigational Site
-
-
Ohio
-
Beachwood, Ohio, Forenede Stater, 44122
- Alkermes Investigational Site
-
Canton, Ohio, Forenede Stater, 44718
- Alkermes Investigational Site
-
Cincinnati, Ohio, Forenede Stater, 45215
- Alkermes Investigational Site
-
Cincinnati, Ohio, Forenede Stater, 45227
- Alkermes Investigational Site
-
Dayton, Ohio, Forenede Stater, 45417
- Alkermes Investigational Site
-
Mason, Ohio, Forenede Stater, 45040
- Alkermes Investigational Site
-
Middleburg Heights, Ohio, Forenede Stater, 44130
- Alkermes Investigational Site
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forenede Stater, 73103
- Alkermes Investigational Site
-
Oklahoma City, Oklahoma, Forenede Stater, 73112
- Alkermes Investigational Site
-
-
Oregon
-
Portland, Oregon, Forenede Stater, 97214
- Alkermes Investigational Site
-
Portland, Oregon, Forenede Stater, 97210
- Alkermes Investigational Site
-
Salem, Oregon, Forenede Stater, 97301
- Alkermes Investigational Site
-
-
Pennsylvania
-
Allentown, Pennsylvania, Forenede Stater, 18104
- Alkermes Investigational Site
-
Media, Pennsylvania, Forenede Stater, 19063
- Alkermes Investigational Site
-
Philadelphia, Pennsylvania, Forenede Stater, 19107
- Alkermes Investigational Site
-
Philadelphia, Pennsylvania, Forenede Stater, 19104
- Alkermes Investigational Site
-
-
Rhode Island
-
Lincoln, Rhode Island, Forenede Stater, 02865
- Alkermes Investigational Site
-
-
South Carolina
-
Charleston, South Carolina, Forenede Stater, 29407
- Alkermes Investigational Site
-
-
Tennessee
-
Memphis, Tennessee, Forenede Stater, 38119
- Alkermes Investigational Site
-
-
Texas
-
Austin, Texas, Forenede Stater, 78731
- Alkermes Investigational Site
-
Dallas, Texas, Forenede Stater, 75231
- Alkermes Investigational Site
-
Dallas, Texas, Forenede Stater, 75390
- Alkermes Investigational Site
-
DeSoto, Texas, Forenede Stater, 75115
- Alkermes Investigational Site
-
Houston, Texas, Forenede Stater, 77081
- Alkermes Investigational Site
-
Houston, Texas, Forenede Stater, 77098
- Alkermes Investigational Site
-
San Antonio, Texas, Forenede Stater, 78229
- Alkermes Investigational Site
-
Sugar Land, Texas, Forenede Stater, 77478
- Alkermes Investigational Site
-
Wichita Falls, Texas, Forenede Stater, 76309
- Alkermes Investigational Site
-
-
Utah
-
Clinton, Utah, Forenede Stater, 84015
- Alkermes Investigational Site
-
-
Vermont
-
Woodstock, Vermont, Forenede Stater, 05091
- Alkermes Investigational Site
-
-
Washington
-
Bellevue, Washington, Forenede Stater, 98007
- Alkermes Investigational Site
-
Seattle, Washington, Forenede Stater, 98104
- Alkermes Investigational Site
-
Spokane, Washington, Forenede Stater, 99204
- Alkermes Investigational Site
-
-
Wisconsin
-
Middleton, Wisconsin, Forenede Stater, 53562
- Alkermes Investigational Site
-
Waukesha, Wisconsin, Forenede Stater, 53188
- Alkermes Investigational Site
-
-
-
-
-
Bialystok, Polen, 15-879
- Alkermes Investigational Site
-
Gdansk, Polen, 80-546
- Alkermes Investigational Site
-
Gdansk, Polen, 80-438
- Alkermes Investigational Site
-
Gorlice, Polen, 38-300
- Alkermes Investigational Site
-
-
-
-
-
San Juan, Puerto Rico, 00918
- Alkermes Investigational Site
-
San Juan, Puerto Rico, 00926
- Alkermes Investigational Site
-
-
-
-
-
Achim, Tyskland, 28832
- Alkermes Investigational Site
-
Berlin, Tyskland, 10245
- Alkermes Investigational Site
-
Berlin, Tyskland, 10629
- Alkermes Investigational Site
-
Berlin, Tyskland, 10365
- Alkermes Investigational Site
-
Ellwangen, Tyskland, 73479
- Alkermes Investigational Site
-
Freiburg, Tyskland, 79104
- Alkermes Investigational Site
-
Hannover, Tyskland, 30159
- Alkermes Investigational Site
-
Mainz, Tyskland, 55131
- Alkermes Investigational Site
-
Schwerin, Tyskland, 19053
- Alkermes Investigational Site
-
Stralsund, Tyskland, 18439
- Alkermes Investigational Site
-
-
Brandenburg
-
Oranienburg, Brandenburg, Tyskland, 16515
- Alkermes Investigational Site
-
-
-
-
-
Budapest, Ungarn, 1053
- Alkermes Investigational Site
-
Budapest, Ungarn, 1135
- Alkermes Investigational Site
-
Budapest, Ungarn, 1137
- Alkermes Investigational Site
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 70 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inklusionskriterier:
- Accepter at bruge en godkendt præventionsmetode i hele undersøgelsens varighed
- Har potentialet til sikkert at drage fordel af administrationen af ALKS 5461
- Har en diagnose af svær depressiv lidelse (MDD)
- Yderligere kriterier kan være gældende
Ekskluderingskriterier:
- Få en positiv test for misbrugsstoffer
- Er i øjeblikket gravid eller ammer
- Har en aktuel primær Axis-I lidelse, som ikke er MDD
- Har brugt opioidagonister (f.eks. kodein, oxycodon, tramadol, morfin) eller opioidantagonister (f.eks. naloxon, naltrexon) inden for 14 dage
- Har modtaget elektrokonvulsiv behandling inden for de sidste 2 år, eller modtaget mere end 1 forløb med elektrokonvulsiv behandling i løbet af deres levetid
- Har forsøgt selvmord inden for de seneste 2 år
- Har en historie med intolerance, allergi eller overfølsomhed over for buprenorphin eller opioidantagonister (f.eks. naltrexon, naloxon)
- Har haft et betydeligt blodtab eller bloddonation inden for de seneste 60 dage
- Yderligere kriterier kan være gældende
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: ALKS 5461
|
Sublingual tablet, taget dagligt
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Hyppighed af uønskede hændelser (AE'er)
Tidsramme: Op til 56 uger
|
Op til 56 uger
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Studieleder: Sanjeev Pathak, MD, Alkermes, Inc.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. maj 2014
Primær færdiggørelse (Faktiske)
20. november 2017
Studieafslutning (Faktiske)
20. november 2017
Datoer for studieregistrering
Først indsendt
15. maj 2014
Først indsendt, der opfyldte QC-kriterier
15. maj 2014
Først opslået (Skøn)
19. maj 2014
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
14. december 2018
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
21. november 2018
Sidst verificeret
1. november 2018
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- ALK5461-208
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Større depressiv lidelse
-
Rotman Research Institute at BaycrestRekrutteringMajor Depressive Disorder (MDD)Canada
-
ACADIA Pharmaceuticals Inc.RekrutteringDepressiv lidelse, behandlingsresistent | Major Depressive Disorder (MDD)Forenede Stater
-
University of PretoriaIkke rekrutterer endnuMajor Depressive Disorder (MDD)Saudi Arabien
-
Tel Aviv UniversityIkke rekrutterer endnuMajor Depressive Disorder (MDD)Israel
-
Yonggui YuanIkke rekrutterer endnuMajor Depressive Disorder (MDD)Kina
-
Daniel LindqvistLund University; KetabonRekrutteringMajor Depressive Disorder (MDD)Sverige
-
King's College LondonCardiff and Vale University Health Board; South London and Maudsley NHS... og andre samarbejdspartnereRekrutteringMajor Depressive Disorder (MDD)Det Forenede Kongerige
-
Supernus Pharmaceuticals, Inc.RekrutteringMajor Depressive Disorder (MDD)Forenede Stater
-
University of PennsylvaniaRekruttering
-
The Second Hospital of Anhui Medical UniversityIkke rekrutterer endnu
Kliniske forsøg med ALKS 5461
-
Senhwa Biosciences, Inc.RekrutteringAvanceret solid tumorForenede Stater, Canada
-
Alkermes, Inc.Afsluttet
-
ALK-Abelló A/SAfsluttetBirkepollenallergiFinland, Holland
-
Alkermes, Inc.AfsluttetNedsat leverfunktionForenede Stater
-
Alkermes, Inc.Afsluttet
-
Karolinska InstitutetAfsluttet
-
Karolinska InstitutetKarolinska University Hospital; Skane University HospitalAfsluttetAllergisk rhinitisSverige
-
ALK-Abelló A/SErgomed; ACM Pivotal Global Central LaboratoryAfsluttet
-
Karolinska InstitutetKarolinska University Hospital; Skane University Hospital; Sodra Alvsborgs...Afsluttet
-
The S.N. Fyodorov Eye Microsurgery State InstitutionAfsluttetHornhindeopacitet | Keratokonus